{
  "metadata": {
    "sourceFile": "Acquired _ Exited Biotechs  Sankey 1.csv",
    "processedDate": "2025-06-11T14:30:00.000Z",
    "totalRecords": 168,
    "dataRange": null,
    "columns": ["Company", "Status"],
    "description": "Analysis of 168 biotech companies that completed IPOs and their current status",
    "statusBreakdown": {
      "Listed": 122,
      "Acquired": 23,
      "Reverse Merged": 10,
      "Liquidated": 5,
      "Bankrupt": 4,
      "OTC Trading": 4
    },
    "strategicBreakdown": {
      "Still Independent": 122,
      "Acquired": 23,
      "Distressed": 23
    },
    "visualization": {
      "chartType": "Enhanced Donut Chart",
      "primaryStory": "73% of biotech IPOs remain independent, challenging acquisition assumptions",
      "keyInsights": [
        "3 in 4 biotech companies remain independent after going public",
        "Only 1 in 7 companies are acquired",
        "Distress rate equals acquisition rate at 13.7%"
      ],
      "emphasisElements": ["Still Independent segment dominance"]
    }
  },
  "companies": [
    {"company": "Akouos", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Ambrx Biopharma", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Calliditas Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Checkmate Pharmaceuticals", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Cincor Pharma", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Decibel Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Dice Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Exscientia", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Forma Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Freeline Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Fusion Pharmaceuticals", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Gracell Biotechnologies", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Icosavax", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Imago BioSciences", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Kinnate Biopharma", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Landos Biopharma", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Pandion Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Poseidon Pharmaceuticals", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Precision BioSciences", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "ProQR Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Sangamo Therapeutics", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Solid Biosciences", "status": "Acquired", "strategicCategory": "Acquired"},
    {"company": "Zentalis Pharmaceuticals", "status": "Acquired", "strategicCategory": "Acquired"}
  ],
  "strategicData": [
    {
      "category": "Still Independent",
      "subcategories": ["Listed"],
      "count": 122,
      "percentage": 72.6,
      "color": "primary",
      "description": "Companies that remain listed and independent",
      "companies": [
        "Example Listed Company 1",
        "Example Listed Company 2"
      ]
    },
    {
      "category": "Acquired",
      "subcategories": ["Acquired"],
      "count": 23,
      "percentage": 13.7,
      "color": "secondary",
      "description": "Companies acquired by other firms",
      "companies": [
        "Akouos",
        "Ambrx Biopharma",
        "Calliditas Therapeutics",
        "Checkmate Pharmaceuticals",
        "Cincor Pharma",
        "Decibel Therapeutics",
        "Dice Therapeutics",
        "Exscientia",
        "Forma Therapeutics",
        "Freeline Therapeutics",
        "Fusion Pharmaceuticals",
        "Gracell Biotechnologies",
        "Icosavax",
        "Imago BioSciences",
        "Kinnate Biopharma",
        "Landos Biopharma",
        "Pandion Therapeutics",
        "Poseidon Pharmaceuticals",
        "Precision BioSciences",
        "ProQR Therapeutics",
        "Sangamo Therapeutics",
        "Solid Biosciences",
        "Zentalis Pharmaceuticals"
      ]
    },
    {
      "category": "Distressed",
      "subcategories": ["Reverse Merged", "Liquidated", "Bankrupt", "OTC Trading"],
      "count": 23,
      "percentage": 13.7,
      "color": "quaternary",
      "description": "Companies experiencing various forms of distress",
      "breakdown": {
        "Reverse Merged": 10,
        "Liquidated": 5,
        "Bankrupt": 4,
        "OTC Trading": 4
      },
      "companies": [
        "Example Reverse Merged Company 1",
        "Example Liquidated Company 1",
        "Example Bankrupt Company 1",
        "Example OTC Trading Company 1"
      ]
    }
  ]
}